The ceramide synthase 2 (CerS2) catalyzes synthesis of long-chain (22:0, 24:0, 24:1) Cer, and reduction in these ceramides is associated with neurodegenerative disorders including epilepsy [26]. The gene discussed is CERS2; the disease is epilepsy.